# CHF COPD Sip Feed Anabolic Response

> **NCT02770092** · NA · COMPLETED · sponsor: **Texas A&M University** · enrollment: 90 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Congestive Heart Failure

## Interventions

- **OTHER:** sip feeding with stable isotope infusion

## Key facts

- **NCT ID:** NCT02770092
- **Lead sponsor:** Texas A&M University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-10
- **Primary completion:** 2018-05-15
- **Final completion:** 2018-05-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770092, "CHF COPD Sip Feed Anabolic Response". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02770092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*